Degarelix and its therapeutic potential in the treatment of prostate cancer

Christian Doehn, Martin Sommerauer, Dieter JochamDepartment of Urology, University of Lübeck Medical School, Lübeck, GermanyAbstract: Degarelix is a gonadotropin-releasing hormone (GnRH) antagonist for the treatment of patients with prostate cancer in whom hormonal therapy is indic...

Full description

Bibliographic Details
Main Authors: Christian Doehn, Martin Sommerauer, Dieter Jocham
Format: Article
Language:English
Published: Dove Medical Press 2009-05-01
Series:Clinical Interventions in Aging
Subjects:
Online Access:https://www.dovepress.com/degarelix-and-its-therapeutic-potential-in-the-treatment-of-prostate-c-peer-reviewed-article-CIA